Daniel Stauder
Stock Analyst at Citizens
(3.44)
# 920
Out of 5,132 analysts
21
Total ratings
50%
Success rate
8.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STXS Stereotaxis | Initiates: Market Outperform | $4 | $2.03 | +97.04% | 1 | Dec 16, 2025 | |
| AORT Artivion | Maintains: Market Outperform | $47 → $53 | $40.10 | +32.17% | 7 | Nov 7, 2025 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $32.95 | +82.09% | 6 | Apr 30, 2025 | |
| STIM Neuronetics | Maintains: Market Outperform | $3 → $7 | $1.80 | +288.89% | 1 | Mar 5, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $87.67 | +25.47% | 4 | Feb 28, 2025 | |
| AXON Axon Enterprise | Reiterates: Market Outperform | $725 | $434.45 | +66.88% | 1 | Feb 26, 2025 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $15.12 | - | 1 | May 7, 2024 |
Stereotaxis
Dec 16, 2025
Initiates: Market Outperform
Price Target: $4
Current: $2.03
Upside: +97.04%
Artivion
Nov 7, 2025
Maintains: Market Outperform
Price Target: $47 → $53
Current: $40.10
Upside: +32.17%
AtriCure
Apr 30, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $32.95
Upside: +82.09%
Neuronetics
Mar 5, 2025
Maintains: Market Outperform
Price Target: $3 → $7
Current: $1.80
Upside: +288.89%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $87.67
Upside: +25.47%
Axon Enterprise
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $725
Current: $434.45
Upside: +66.88%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $15.12
Upside: -